8225 Stock Overview
An investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
China Health Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.18 |
| 52 Week High | HK$0.24 |
| 52 Week Low | HK$0.04 |
| Beta | -2.34 |
| 1 Month Change | 1.12% |
| 3 Month Change | 41.73% |
| 1 Year Change | 38.46% |
| 3 Year Change | -55.00% |
| 5 Year Change | 74.76% |
| Change since IPO | -56.10% |
Recent News & Updates
Recent updates
Does China Health Group (HKG:8225) Deserve A Spot On Your Watchlist?
Jan 28
Should You Be Adding China Health Group (HKG:8225) To Your Watchlist Today?
Apr 14Announcing: China Health Group (HKG:8225) Stock Increased An Energizing 170% In The Last Five Years
Mar 09Is China Health Group Inc.'s (HKG:8225) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 10
Does China Health Group (HKG:8225) Deserve A Spot On Your Watchlist?
Jan 14If You Had Bought China Health Group (HKG:8225) Stock A Year Ago, You Could Pocket A 546% Gain Today
Nov 26Shareholder Returns
| 8225 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | 2.3% | 1.6% | -0.5% |
| 1Y | 38.5% | -32.2% | 19.9% |
Return vs Industry: 8225 exceeded the Hong Kong Life Sciences industry which returned -32.2% over the past year.
Return vs Market: 8225 exceeded the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 8225 volatility | |
|---|---|
| 8225 Average Weekly Movement | 26.3% |
| Life Sciences Industry Average Movement | 12.1% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 8225's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8225's weekly volatility has increased from 17% to 26% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 41 | n/a | www.chgi.net |
China Health Group Inc., an investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; and post launch market research, medical, and medical market services. It also provides hospital management, clinical research and promotion, and specialized hospital services, as well as Venturepharma health cloud; and tourism recovery services.
China Health Group Inc. Fundamentals Summary
| 8225 fundamental statistics | |
|---|---|
| Market cap | HK$179.16m |
| Earnings (TTM) | -HK$60.20m |
| Revenue (TTM) | HK$26.32m |
6.8x
P/S Ratio-3.0x
P/E RatioIs 8225 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8225 income statement (TTM) | |
|---|---|
| Revenue | CN¥24.69m |
| Cost of Revenue | CN¥14.19m |
| Gross Profit | CN¥10.51m |
| Other Expenses | CN¥67.00m |
| Earnings | -CN¥56.49m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.057 |
| Gross Margin | 42.55% |
| Net Profit Margin | -228.76% |
| Debt/Equity Ratio | 0% |
How did 8225 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:18 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Health Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|